Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

FIRAS S AHMED

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1427341551
CMS profile
3121642
Location
NEW YORK, NY

General Payments · PY2019–2023

$109,315.29

  • Reported across 60 records
  • CMS publication 2026-06-30

Latest program year · PY2023

$84,360.00

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $84,360.00 14

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $68,535.00 12
Boehringer Ingelheim International GmbH $15,825.00 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $11,146.17 22
PY2021 $10,430.00 14
PY2022 $3,379.12 10
PY2023 $84,360.00 14

Payment records · PY2023 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2023 201920212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim International GmbH $6,675.00 09/01/2023 Consulting Fee Undisputed 06/30/2026 1017328527 CMS
Boehringer Ingelheim International GmbH $9,150.00 10/02/2023 Consulting Fee Undisputed 06/30/2026 1017328521 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,510.00 01/03/2023 Consulting Fee Undisputed 06/30/2026 996453005 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,710.00 02/01/2023 Consulting Fee Undisputed 06/30/2026 996453001 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $3,525.00 03/01/2023 Consulting Fee Undisputed 06/30/2026 996452969 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $5,700.00 04/03/2023 Consulting Fee Undisputed 06/30/2026 996452973 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $4,575.00 05/01/2023 Consulting Fee Undisputed 06/30/2026 997147241 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $4,610.00 06/01/2023 Consulting Fee Undisputed 06/30/2026 996452977 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6,890.00 07/03/2023 Consulting Fee Undisputed 06/30/2026 996452997 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7,275.00 08/01/2023 Consulting Fee Undisputed 06/30/2026 996452993 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $5,055.00 09/01/2023 Consulting Fee Undisputed 06/30/2026 997147245 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $10,155.00 10/02/2023 Consulting Fee Undisputed 06/30/2026 996452989 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7,825.00 11/01/2023 Consulting Fee Undisputed 06/30/2026 996452981 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6,705.00 12/01/2023 Consulting Fee Undisputed 06/30/2026 996452985 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.